People | Locations | Statistics |
---|---|---|
Naji, M. |
| |
Motta, Antonella |
| |
Aletan, Dirar |
| |
Mohamed, Tarek |
| |
Ertürk, Emre |
| |
Taccardi, Nicola |
| |
Kononenko, Denys |
| |
Petrov, R. H. | Madrid |
|
Alshaaer, Mazen | Brussels |
|
Bih, L. |
| |
Casati, R. |
| |
Muller, Hermance |
| |
Kočí, Jan | Prague |
|
Šuljagić, Marija |
| |
Kalteremidou, Kalliopi-Artemi | Brussels |
|
Azam, Siraj |
| |
Ospanova, Alyiya |
| |
Blanpain, Bart |
| |
Ali, M. A. |
| |
Popa, V. |
| |
Rančić, M. |
| |
Ollier, Nadège |
| |
Azevedo, Nuno Monteiro |
| |
Landes, Michael |
| |
Rignanese, Gian-Marco |
|
Nakamura, Tadashi
in Cooperation with on an Cooperation-Score of 37%
Topics
Publications (1/1 displayed)
Places of action
Organizations | Location | People |
---|
article
Serum amyloid A1 (SAA1) gene polymorphisms in Japanese patients with adult-onset Still's disease
Abstract
<jats:sec><jats:title>Abstract</jats:title><jats:p>Adult-onset Still's disease (AOSD) is a rare systemic inflammatory disorder in which inflammasome activation plays a pathophysiological role. In view of the inflammatory nature of AOSD, we investigated whether serum amyloid A (SAA) gene polymorphisms affect the susceptibility of patients with AOSD.</jats:p><jats:p>Eighty-seven Japanese patients with AOSD and 200 healthy Japanese subjects were recruited in this study. The genotypes of the -13C/T SNP in the 5′-flanking region of the <jats:italic toggle="yes">SAA1</jats:italic> gene (rs12218) and two SNPs within exon 3 of SAA1 (2995C/T and 3010C/T polymorphisms) were determined using polymerase chain reaction fragment length polymorphism (PCR-RFLP) assay in all subjects. In AOSD patients, exons 1, 2, 3, and 10 of the <jats:italic toggle="yes">MEFV</jats:italic> gene were also genotyped by direct sequencing.</jats:p><jats:p>The frequency of the S<jats:italic toggle="yes">AA1.3</jats:italic> allele was increased in AOSD patients compared with that in healthy subjects (43.1% versus 37.5%), but the difference was not significant. The −13T allele was more frequently observed in AOSD patients than in healthy subjects (50.6% versus 41.0%, <jats:italic toggle="yes">P</jats:italic> = .0336). AOSD patients with the −13T allele had been treated with immunosuppressants more frequently than those without this allele. <jats:italic toggle="yes">MEFV</jats:italic> mutations were detected in 49 patients with AOSD (49/87, 57.3%). AOSD patients with <jats:italic toggle="yes">MEFV</jats:italic> variants frequently exhibit macrophage activation syndrome, but the difference was not significant (34.7% versus 18.4%, <jats:italic toggle="yes">P</jats:italic> = .081). Also, there was no significant difference in SAA1 -13C/T allele frequency between AOSD patients with and without <jats:italic toggle="yes">MEFV</jats:italic> mutations.</jats:p><jats:p>Our data shows a significant association between T allele of rs12218 and AOSD in Japanese population.</jats:p></jats:sec>